Clinical Trials Logo

Clinical Trial Summary

The investigators would like to assess if the intake of high bicarbonate mineral water would not only increase total fluid intake but will also be able to give patients the additional benefit of correcting the urinary abnormalities which may predispose them to stone formation.


Clinical Trial Description

The life time risk of developing nephrolithiasis is about 10-15% in the western world, but can be as high as 20-25% in the middle east. Evidence suggests that the incidence and prevalence of kidney stones is increasing globally which represent a significant economic burden. Besides the lack of hydration, the most common metabolic abnormalities associated with calcium stones are hypercalciuria, hypocitraturia and hyperoxaluria. In addition, low urinary pH from consumption of non-dairy animal protein has been associated with reduced urinary citrate and increased uric acid stones which form a nidus for subsequent calcium oxalate precipitates. Dietary modification is the first line approach in the treatment of idiopathic calcium oxalate (CaOx) nephrolithiasis. General advice includes adequate hydration, avoiding oxalate-rich foods, and consumption of an adequate amount of calcium. Adequate hydration is an easy and effective way of preventing stones. Siener et al found in healthy men, consumption of mineral water rich in magnesium and bicarbonate resulted in favourable changes in urinary pH, magnesium and citrate excretion (inhibitors of CaOx stone formation). Our pilot study in 10 young and healthy surgical residents also revealed similar results after drinking bicarbonate rich mineral water for 1 week. In this study, the investigators compared the effect of drinking bicarbonate rich mineral water with plain water on urine biochemistry in a prospective randomized study in patients with known CaOx stones. The investigators hypothesize that the intake of bicarbonate rich mineral water, particularly at meal times, reduces stone risk via reduction in urinary oxalate through increased intestinal oxalate binding with dietary calcium. Other potential benefits of mineral water include increased urinary stone inhibitors like magnesium, citrate and alkalinisation of urine. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04638166
Study type Interventional
Source Singapore General Hospital
Contact
Status Active, not recruiting
Phase N/A
Start date January 25, 2018
Completion date January 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04169165 - Patient Compliance for Metabolic Evaluation and Medical Management in Calcium Stone Patients
Recruiting NCT04669860 - Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma
Enrolling by invitation NCT01127854 - Pilot Study to Evaluate the Contribution of Gene Variants to Idiopathic Urolithiasis
Active, not recruiting NCT05081960 - Evaluating the Vitamin K2 Status of Calcium-based Stone Formers
Active, not recruiting NCT03752684 - Oxalobacter Formigenes Colonization and Urinary Oxalate Excretion N/A